Quest for the right Drug
טריטייס קומפ 5 מ"ג / 25 מ"ג TRITACE COMP 5 MG/25 MG (HYDROCHLOROTHIAZIDE, RAMIPRIL)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
טבליה : TABLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Summary of safety profile The safety profile of ramipril + hydrochlorothiazide includes adverse reactions occurring in the context of hypotension and/or fluid depletion due to increased diuresis. The ramipril active substance may induce persistent dry cough, while the hydrochlorothiazide active substance may lead to worsening of glucose, lipid and uric acid metabolism. The two active substances have inverse effects on plasma potassium. Serious adverse reactions include angioedema or anaphylactic reaction, renal or hepatic impairment, pancreatitis, severe skin reactions and neutropenia/agranulocytosis. Tabulated list of adverse reactions Adverse reactions frequency is defined using the following convention: Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Common Uncommon Very rare Not known Neoplasms Non-melanoma benign, skin cancer* malignant and (Basal cell unspecified carcinoma and (incl cysts and Squamous cell polyps) carcinoma) *Non-melanoma skin cancer: Based on available data from epidemiological studies, cumulative dose-dependent association between HCTZ and NMSC has been observed (see also sections 4.4 and 5.1). Blood and White blood cell Bone marrow lymphatic count failure, system decreased, red neutropenia disorders blood cell count including decreased, agranulocytosis, haemoglobin pancytopenia, decreased, eosinophilia, haemolytic haemoconcentratio anaemia, n in the context of platelet count fluid depletion decreased Immune system Anaphylactic or disorders anaphylactoid reactions to either ramipril or anaphylactic reaction to hydrochlorothiazid e, antinuclear antibody increased Endocrine Syndrome of disorders inappropriate antidiuretic hormone secretion (SIADH) Metabolism and Diabetes Anorexia, Blood Blood sodium nutrition mellitus decreased potassium decreased disorders inadequate appetite increased due control, to ramipril Glycosuria, glucose Blood metabolic tolerance potassium alkalosis, decreased, decreased, hypochloraemia, blood glucose thirst due to hypomagnesaemia increased, hydrochlorothia , hypercalcaemia, blood uric acid zide dehydration due to increased, hydrochlorothiazid gout e aggravated, blood cholesterol and/or triglycerides increased due to hydrochlorothi azide Psychiatric Depressed Confusional state, disorders mood, apathy, restlessness, anxiety, disturbance in nervousness, attention sleep disorders including somnolence Nervous system Headache, Vertigo, Cerebral disorders dizziness paraesthesia, ischaemia tremor, balance including disorder, ischaemic stroke burning and transient sensation, ischaemic attack, dysgeusia, psychomotor skills ageusia impaired, parosmia Eye disorders Visual Xanthopsia, disturbance lacrimation including decreased due to blurred vision, hydrochlorothiazid conjunctivitis e; choroidal effusion, secondary acute angle- closure glaucoma and/or acute myopia due to hydrochlorothiazid e Ear and Tinnitus Hearing impaired labyrinth disorders Cardiac Myocardial Myocardial disorders ischaemia infarction including angina pectoris, tachycardia, arrhythmia, palpitations, oedema peripheral Vascular Hypotension, Thrombosis in the disorders orthostatic context of severe blood pressure fluid depletion, decreased, vascular stenosis, hypoperfusion, syncope, Raynaud’s flushing phenomenon, vasculitis Respiratory, Non-productive Sinusitis, Acute Bronchospasm thoracic and tickling cough, dyspnoea, respiratory including asthma mediastinal bronchitis nasal distress aggravated disorders congestion syndrome (ARDS) (see Alveolitis allergic, section 4.4) non cardiogenic pulmonary oedema due to hydrochlorothiazid e Gastrointestinal Gastrointestinal Vomiting, Pancreatitis (cases disorders inflammation, aphtous of fatal outcome digestive stomatitis, have been very disturbances, glossitis, exceptionally abdominal diarrhoea, reported with ACE discomfort, abdominal inhibitors), dyspepsia, pain upper, pancreatic gastritis, dry mouth enzymes nausea, increased, small constipation bowel angioedema Gingivitis due to Sialoadenitis due hydrochlorothia to zide hydrochlorothiazid e Hepatobiliary Cholestatic or Acute hepatic disorders cytolytic failure, jaundice hepatitis (fatal cholestatic, outcome has hepatocellular been very damage exceptional), hepatic enzyme and/or bilirubin conjugated increased Calculous cholecystitis due to hydrochlorothia zide Skin and Angioedema: Toxic epidermal subcutaneous very necrolysis, tissue disorders exceptionally, Stevens-Johnson the airway syndrome, obstruction erythema resulting from multiforme, angioedema pemphigus, may have a psoriasis fatal outcome; aggravated, dermatitis exfoliative psoriasiform, dermatitis, hyperhidrosis, photosensitivity rash, in reaction, particular onycholysis, maculo-papular, pemphigoid or pruritus, lichenoid alopecia exanthema or enanthema, urticaria Systemic lupus erythematosus due to hydrochlorothiazid e Musculoskeletal Myalgia Arthralgia, muscle and connective spasms tissue disorders Muscular weakness, musculoskeletal stiffness, tetany due to hydrochlorothiazid e Renal and Renal Worsening of a urinary impairment pre-existing disorders including renal proteinuria failure acute, urine output Interstitial nephritis increased, due to blood urea hydrochlorothiazid increased, e blood creatinine increased Reproductive Transient Libido decreased, system and erectile gynaecomastia breast disorders impotence General Fatigue, Chest pain, disorders and asthenia pyrexia administration site conditions Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il/
מסגרת הכללה בסל
התוויות הכלולות במסגרת הסל
התוויה | תאריך הכללה | תחום קליני | Class Effect | מצב מחלה |
---|---|---|---|---|
לב וכלי דם | CILAZAPRIL, FOSINOPRIL, MOEXIPRIL, RAMIPRIL |
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
01/03/2001
הגבלות
תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת
מידע נוסף
עלון מידע לצרכן
08.11.21 - עלון לצרכן אנגלית 12.05.22 - עלון לצרכן עברית 08.11.21 - עלון לצרכן ערבית 10.10.22 - עלון לצרכן אנגלית 10.10.22 - עלון לצרכן עברית 10.10.22 - עלון לצרכן ערבית 23.08.13 - החמרה לעלון 24.03.14 - החמרה לעלון 22.03.16 - החמרה לעלון 20.03.17 - החמרה לעלון 11.08.20 - החמרה לעלון 05.04.21 - החמרה לעלון 03.11.23 - החמרה לעלוןלתרופה במאגר משרד הבריאות
טריטייס קומפ 5 מ"ג / 25 מ"ג